Dr. Cavender is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Cir
Chapel Hill, NC 27517Phone+1 984-974-2900Fax+1 984-974-2985
Education & Training
- Brigham and Womens HospitalFellowship, Structural and Peripheral Cardiology, 2015 - 2016
- Brigham and Women's HospitalFellowship, Interventional Cardiology, 2014 - 2015
- Brigham and Women's HospitalPost-Doctoral Fellowship, 2012 - 2014
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2009 - 2012
- Duke University HospitalResidency, Internal Medicine, 2006 - 2009
- University of Alabama School of MedicineClass of 2006
Certifications & Licensure
- NH State Medical License 2015 - Present
- NC State Medical License 2006 - 2026
- MA State Medical License 2012 - 2021
- AL State Medical License 2014 - 2014
- OH State Medical License 2009 - 2013
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- Promoting Shared Decision Making for Severe Aortic Stenosis Start of enrollment: 2024 Mar 27
Roles: Contact
Publications & Presentations
PubMed
- Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.Adam J Nelson, Lisa A Kaltenbach, Darren K McGuire, Monica Levya, Hussein R Al-Khalidi
American Heart Journal. 2025-04-01 - The IMproving treatment decisions for Patients with AortiC stenosis Through Shared Decision Making (IMPACT SDM) Study: study protocol for a cluster randomized stepped ...Karen Sepucha, Sammy Elmariah, K D Valentine, Matthew A Cavender, Yuchiao Chang
Trials. 2024-12-18 - 1 citationsHow Can We Increase the Utilization of Evidence-Based Medication After Myocardial Infarction?Matthew A Cavender, Sidney C Smith Jr
JAMA Network Open. 2024-11-04
Press Mentions
- Novel Therapies: Using GLP-1 Receptor Agonists in Cardiorenal Metabolic SyndromeAugust 20th, 2024
- Special Issue of JACC Examines Public Health Impact of CVD and Its PreventionMay 28th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: